Details

Title
Author Correction: Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer
Author
Troiani, Martina 1 ; Colucci, Manuel 2 ; D’Ambrosio, Mariantonietta 2 ; Guccini, Ilaria 3 ; Pasquini, Emiliano 4 ; Varesi, Angelica 4 ; Valdata, Aurora 4 ; Mosole, Simone 4 ; Revandkar, Ajinkya 5 ; Attanasio, Giuseppe 4 ; Rinaldi, Andrea 4 ; Rinaldi, Anna 6 ; Bolis, Marco 7   VIAFID ORCID Logo  ; Cippà, Pietro 6 ; Alimonti, Andrea 8   VIAFID ORCID Logo 

 Oncology Institute of Southern Switzerland (IOSI), Institute of Oncology Research (IOR), Bellinzona, Switzerland (GRID:grid.419922.5); Università della Svizzera Italiana, Lugano, Switzerland (GRID:grid.29078.34) (ISNI:0000 0001 2203 2861); Swiss Institute of Bioinformatics, TI, Bioinformatics Core Unit, Bellinzona, Switzerland (GRID:grid.481132.d) (ISNI:0000 0004 0509 2899) 
 Oncology Institute of Southern Switzerland (IOSI), Institute of Oncology Research (IOR), Bellinzona, Switzerland (GRID:grid.419922.5); Università della Svizzera Italiana, Lugano, Switzerland (GRID:grid.29078.34) (ISNI:0000 0001 2203 2861); University of Lausanne UNIL, Faculty of Biology and Medicine, Lausanne, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204) 
 ETH Zurich, Institute of Molecular Health Sciences, Zurich, Switzerland (GRID:grid.5801.c) (ISNI:0000 0001 2156 2780) 
 Oncology Institute of Southern Switzerland (IOSI), Institute of Oncology Research (IOR), Bellinzona, Switzerland (GRID:grid.419922.5); Università della Svizzera Italiana, Lugano, Switzerland (GRID:grid.29078.34) (ISNI:0000 0001 2203 2861) 
 Oncology Institute of Southern Switzerland (IOSI), Institute of Oncology Research (IOR), Bellinzona, Switzerland (GRID:grid.419922.5); Università della Svizzera Italiana, Lugano, Switzerland (GRID:grid.29078.34) (ISNI:0000 0001 2203 2861); Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
 Ente Ospedaliero Cantonale, Department of Medicine, Division of Nephrology, Lugano, Switzerland (GRID:grid.469433.f) (ISNI:0000 0004 0514 7845); Ente Ospedaliero Cantonale, Laboratories for Translational Research, Bellinzona, Switzerland (GRID:grid.469433.f) (ISNI:0000 0004 0514 7845) 
 Oncology Institute of Southern Switzerland (IOSI), Institute of Oncology Research (IOR), Bellinzona, Switzerland (GRID:grid.419922.5); Università della Svizzera Italiana, Lugano, Switzerland (GRID:grid.29078.34) (ISNI:0000 0001 2203 2861); Swiss Institute of Bioinformatics, TI, Bioinformatics Core Unit, Bellinzona, Switzerland (GRID:grid.481132.d) (ISNI:0000 0004 0509 2899); Istituto di Ricerche Farmacologiche ‘Mario Negri’ IRCCS, Computational Oncology Unit, Department of Oncology, Milano, Italy (GRID:grid.4527.4) (ISNI:0000000106678902) 
 Oncology Institute of Southern Switzerland (IOSI), Institute of Oncology Research (IOR), Bellinzona, Switzerland (GRID:grid.419922.5); Università della Svizzera Italiana, Lugano, Switzerland (GRID:grid.29078.34) (ISNI:0000 0001 2203 2861); Department of Health Sciences and Technology (D-HEST) ETH Zurich, Zurich, Switzerland (GRID:grid.5801.c) (ISNI:0000 0001 2156 2780); University of Padova, Department of Medicine & Veneto Institute of Molecular Medicine, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470) 
Pages
4386
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2840081647
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.